Zhongzhi Pharmaceutical Holdings Limited (03737) Announces Monthly Return for February 2026
Bulletin Express
Yesterday
Zhongzhi Pharmaceutical Holdings Limited provided its monthly return for equity issuers as of 28 February 2026. The company maintained an authorized share capital of 1,560,000,000 ordinary shares at a par value of HKD 0.01 per share, totaling HKD 15.60 million. No changes occurred in authorized share capital or in the issued share quantity, which remained 863.60 million shares.
The report confirms compliance with the applicable public float requirement. No share options, warrants, convertible securities, or other arrangements were recorded during the month.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.